Evidence method
Level · gp.fundamentals.debt_to_revenue
48683.98% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BTAI · Mar 31, 2026
BioXcel Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001104659-26-061769General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-5732.52% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
22.62% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
242.72% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
-37.38% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-4962.62% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1434.47% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
211.16% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/6 normalizedLevel 3Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20246/7 normalizedLevel 3Dec 31, 20246/7 normalizedLevel 3Mar 31, 20256/8 normalizedLevel 3Jun 30, 20256/8 normalizedLevel 3Sep 30, 20257/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20267/9 normalizedLevel 3Jun 30, 20267/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 17070.72%
- Current
- 48683.98%
- Delta
- 31613.26%
- Previous
- -8974.30%
- Current
- -5732.52%
- Delta
- 3241.77%
- Previous
- -71.67%
- Current
- 22.62%
- Delta
- 94.29%
- Previous
- 112.46%
- Current
- 242.72%
- Delta
- 130.26%
- Previous
- 74.45%
- Current
- -37.38%
- Delta
- -111.83%
- Previous
- -7859.97%
- Current
- -4962.62%
- Delta
- 2897.35%
- Previous
- 4711.99%
- Current
- 1434.47%
- Delta
- -3277.53%
- Previous
- 431.00%
- Current
- 211.16%
- Delta
- -219.83%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BTAI Fundamental State →Transitioned To · BTAI BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · BTAI CASH_GENERATION_INCREASED →Transitioned To · BTAI GROWTH_INCREASED →Transitioned To · BTAI INVENTORY_PRESSURE_INCREASED →Transitioned To · BTAI MARGIN_DECREASED →Transitioned To · BTAI PROFITABILITY_INCREASED →Transitioned To · BTAI R_AND_D_INTENSITY_DECREASED →Transitioned To · BTAI SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.